{"transactions":[{"id":711921,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-07-09T20:15:05.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":266,"price":4.5305,"value":1205.113,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":19270,"source":{"system":"sec-edgar","filing":"0001903669-26-000006","document":"form4-07092026_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366926000006/form4-07092026_040701.xml","form_type":"4"}},{"id":952077,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-01-05T21:43:53.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":4690,"price":4.5305,"value":21248.045,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).  The Reporting Person acquired the maximum shares allowable pursuant to Section 423 of the Internal Revenue Code."}],"balance_after":19004,"source":{"system":"sec-edgar","filing":"0001903669-26-000002","document":"form4-01052026_090149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366926000002/form4-01052026_090149.xml","form_type":"4"}},{"id":965350,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-12-17T21:56:43.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":1196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On December 14, 2023, the Reporting Person was granted a total of 9,658 RSUs. 50% or 4,784 of the total RSUs are performance-based and all vested on December 10, 2024. An addition of 50% or 4,784 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2025, 1,196 shares vested and 608 shares were withheld for taxes, resulting in a net issuance of 588 shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On December 14, 2023, the Reporting Person was granted a total of 9,658 RSUs. 50% or 4,784 of the total RSUs are performance-based and all vested on December 10, 2024. An addition of 50% or 4,784 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2025, 1,196 shares vested and 608 shares were withheld for taxes, resulting in a net issuance of 588 shares."}],"balance_after":2392,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1196},"source":{"system":"sec-edgar","filing":"0001903669-25-000010","document":"form4-12172025_091239.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000010/form4-12172025_091239.xml","form_type":"4"}},{"id":965349,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-12-17T21:56:43.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":1480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 5, 2022, the Reporting Person was granted 5,920 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs vested on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2025, 1,480 RSUs vested, with 752 shares withheld for taxes, resulting in a net issuance of 728 shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On December 5, 2022, the Reporting Person was granted 5,920 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs vested on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2025, 1,480 RSUs vested, with 752 shares withheld for taxes, resulting in a net issuance of 728 shares."}],"balance_after":1480,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1480},"source":{"system":"sec-edgar","filing":"0001903669-25-000010","document":"form4-12172025_091239.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000010/form4-12172025_091239.xml","form_type":"4"}},{"id":965348,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-17T21:56:43.000Z","date":"2025-12-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 11, 2025 (the \"Repricing Date\"). The Option Repricing applies to options with exercise prices of $106.09 per share or greater held by employees and directors of the Issuer who remained in continuous service with the Company as of the Repricing Date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $104.13 per share, the thirty (30)-day trailing volume-weighted average price of the Common Stock on the Nasdaq Capital Market on the Repricing Date. However, if an optionholder exercises a repriced option before the end of a retention period of one year (which period may be shorter in certain circumstances), such optionholder will be required to pay the original exercise price per share of such repriced option. No other changes were made to the repriced options in connection with the Option Repricing, including with respect to the vesting schedules, expiration dates or number of shares underlying such repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares vest upon the achievement of specified performance goals, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). 50% or 1,666 shares of the total shares vested on November 26, 2023.  50% or 1,666 shares of the total shares did not vest as the relevant performance goal was not achieved."}],"balance_after":0,"derivative":{"exercise_price":344.25,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":1666},"source":{"system":"sec-edgar","filing":"0001903669-25-000010","document":"form4-12172025_091239.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000010/form4-12172025_091239.xml","form_type":"4"}},{"id":965347,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-17T21:56:43.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":1666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 11, 2025 (the \"Repricing Date\"). The Option Repricing applies to options with exercise prices of $106.09 per share or greater held by employees and directors of the Issuer who remained in continuous service with the Company as of the Repricing Date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $104.13 per share, the thirty (30)-day trailing volume-weighted average price of the Common Stock on the Nasdaq Capital Market on the Repricing Date. However, if an optionholder exercises a repriced option before the end of a retention period of one year (which period may be shorter in certain circumstances), such optionholder will be required to pay the original exercise price per share of such repriced option. No other changes were made to the repriced options in connection with the Option Repricing, including with respect to the vesting schedules, expiration dates or number of shares underlying such repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares vest upon the achievement of specified performance goals, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). 50% or 1,666 shares of the total shares vested on November 26, 2023.  50% or 1,666 shares of the total shares did not vest as the relevant performance goal was not achieved."}],"balance_after":1666,"derivative":{"exercise_price":104.13,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":1666},"source":{"system":"sec-edgar","filing":"0001903669-25-000010","document":"form4-12172025_091239.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000010/form4-12172025_091239.xml","form_type":"4"}},{"id":965346,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-12-17T21:56:43.000Z","date":"2025-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":608,"price":80.67,"value":49047.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On December 14, 2023, the Reporting Person was granted a total of 9,658 RSUs. 50% or 4,784 of the total RSUs are performance-based and all vested on December 10, 2024. An addition of 50% or 4,784 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2025, 1,196 shares vested and 608 shares were withheld for taxes, resulting in a net issuance of 588 shares."}],"balance_after":14314,"source":{"system":"sec-edgar","filing":"0001903669-25-000010","document":"form4-12172025_091239.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000010/form4-12172025_091239.xml","form_type":"4"}},{"id":965345,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-12-17T21:56:43.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":true,"shares":1196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On December 14, 2023, the Reporting Person was granted a total of 9,658 RSUs. 50% or 4,784 of the total RSUs are performance-based and all vested on December 10, 2024. An addition of 50% or 4,784 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2025, 1,196 shares vested and 608 shares were withheld for taxes, resulting in a net issuance of 588 shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":14922,"source":{"system":"sec-edgar","filing":"0001903669-25-000010","document":"form4-12172025_091239.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000010/form4-12172025_091239.xml","form_type":"4"}},{"id":965344,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-12-17T21:56:43.000Z","date":"2025-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":752,"price":80.67,"value":60663.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 5, 2022, the Reporting Person was granted 5,920 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs vested on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2025, 1,480 RSUs vested, with 752 shares withheld for taxes, resulting in a net issuance of 728 shares."}],"balance_after":13726,"source":{"system":"sec-edgar","filing":"0001903669-25-000010","document":"form4-12172025_091239.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000010/form4-12172025_091239.xml","form_type":"4"}},{"id":965343,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-12-17T21:56:43.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":true,"shares":1480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 5, 2022, the Reporting Person was granted 5,920 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs vested on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2025, 1,480 RSUs vested, with 752 shares withheld for taxes, resulting in a net issuance of 728 shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":14478,"source":{"system":"sec-edgar","filing":"0001903669-25-000010","document":"form4-12172025_091239.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000010/form4-12172025_091239.xml","form_type":"4"}},{"id":969692,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-15T23:52:04.000Z","date":"2025-12-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 11, 2025 (the \"Repricing Date\"). The Option Repricing applies to options with exercise prices of $106.09 per share or greater held by employees and directors of the Issuer who remained in continuous service with the Company as of the Repricing Date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $104.13 per share, the thirty (30)-day trailing volume-weighted average price of the Common Stock on the Nasdaq Capital Market on the Repricing Date. However, if an optionholder exercises a repriced option before the end of a retention period of one year (which period may be shorter in certain circumstances), such optionholder will be required to pay the original exercise price per share of such repriced option. No other changes were made to the repriced options in connection with the Option Repricing, including with respect to the vesting schedules, expiration dates or number of shares underlying such repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the stock option vest over a four-year period commencing January 3, 2022, with 1/4th of the shares vested on January 3, 2023 and 1/36th of the remaining shares vesting on a monthly basis, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."}],"balance_after":0,"derivative":{"exercise_price":344.25,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001903669-25-000008","document":"form4-12152025_111200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000008/form4-12152025_111200.xml","form_type":"4"}},{"id":969691,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-15T23:52:04.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 11, 2025 (the \"Repricing Date\"). The Option Repricing applies to options with exercise prices of $106.09 per share or greater held by employees and directors of the Issuer who remained in continuous service with the Company as of the Repricing Date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $104.13 per share, the thirty (30)-day trailing volume-weighted average price of the Common Stock on the Nasdaq Capital Market on the Repricing Date. However, if an optionholder exercises a repriced option before the end of a retention period of one year (which period may be shorter in certain circumstances), such optionholder will be required to pay the original exercise price per share of such repriced option. No other changes were made to the repriced options in connection with the Option Repricing, including with respect to the vesting schedules, expiration dates or number of shares underlying such repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the stock option vest over a four-year period commencing January 3, 2022, with 1/4th of the shares vested on January 3, 2023 and 1/36th of the remaining shares vesting on a monthly basis, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."}],"balance_after":10000,"derivative":{"exercise_price":104.13,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001903669-25-000008","document":"form4-12152025_111200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000008/form4-12152025_111200.xml","form_type":"4"}},{"id":971437,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-12-13T00:03:14.000Z","date":"2025-12-11","kind":"exercise","planned":false,"acquired":false,"shares":4950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the total number of RSUs vested on grant. 25% of the total number of RSUs will vest on December 15, 2026, December 15, 2027 and December 15, 2028, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date. On December 11, 2025, 4,950 shares vested and 2,194 shares were withheld for taxes, resulting in a net issuance of 2,756 shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the total number of RSUs vested on grant. 25% of the total number of RSUs will vest on December 15, 2026, December 15, 2027 and December 15, 2028, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date. On December 11, 2025, 4,950 shares vested and 2,194 shares were withheld for taxes, resulting in a net issuance of 2,756 shares."}],"balance_after":14850,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4950},"source":{"system":"sec-edgar","filing":"0001903669-25-000006","document":"form4-12132025_121210.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000006/form4-12132025_121210.xml","form_type":"4"}},{"id":971436,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-12-13T00:03:14.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":19800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the total number of RSUs vested on grant. 25% of the total number of RSUs will vest on December 15, 2026, December 15, 2027 and December 15, 2028, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date. On December 11, 2025, 4,950 shares vested and 2,194 shares were withheld for taxes, resulting in a net issuance of 2,756 shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the total number of RSUs vested on grant. 25% of the total number of RSUs will vest on December 15, 2026, December 15, 2027 and December 15, 2028, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date. On December 11, 2025, 4,950 shares vested and 2,194 shares were withheld for taxes, resulting in a net issuance of 2,756 shares."}],"balance_after":19800,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":19800},"source":{"system":"sec-edgar","filing":"0001903669-25-000006","document":"form4-12132025_121210.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000006/form4-12132025_121210.xml","form_type":"4"}},{"id":971435,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-12-13T00:03:14.000Z","date":"2025-12-10","kind":"exercise","planned":false,"acquired":false,"shares":1196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 14, 2024, the Reporting Person was granted a total of 4,784 RSU's.  Subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date, 25% of the total number of RSUs vested on December 10, 2025, the first anniversary of the achievement of a specified clinical development objective.  25% of the total number of RSUs will vest on each of the second, third and fourth anniversaries of such achievement.  On December 10, 2025, 1,196 shares vested and 428 shares were withheld for taxes, resulting in a net issuance of 768 shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On March 14, 2024, the Reporting Person was granted a total of 4,784 RSU's.  Subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date, 25% of the total number of RSUs vested on December 10, 2025, the first anniversary of the achievement of a specified clinical development objective.  25% of the total number of RSUs will vest on each of the second, third and fourth anniversaries of such achievement.  On December 10, 2025, 1,196 shares vested and 428 shares were withheld for taxes, resulting in a net issuance of 768 shares."}],"balance_after":3588,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1196},"source":{"system":"sec-edgar","filing":"0001903669-25-000006","document":"form4-12132025_121210.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000006/form4-12132025_121210.xml","form_type":"4"}},{"id":971434,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-12-13T00:03:14.000Z","date":"2025-12-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2194,"price":88.41,"value":193971.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"25% of the total number of RSUs vested on grant. 25% of the total number of RSUs will vest on December 15, 2026, December 15, 2027 and December 15, 2028, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date. On December 11, 2025, 4,950 shares vested and 2,194 shares were withheld for taxes, resulting in a net issuance of 2,756 shares."}],"balance_after":12998,"source":{"system":"sec-edgar","filing":"0001903669-25-000006","document":"form4-12132025_121210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000006/form4-12132025_121210.xml","form_type":"4"}},{"id":971433,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-12-13T00:03:14.000Z","date":"2025-12-11","kind":"exercise","planned":false,"acquired":true,"shares":4950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"25% of the total number of RSUs vested on grant. 25% of the total number of RSUs will vest on December 15, 2026, December 15, 2027 and December 15, 2028, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date. On December 11, 2025, 4,950 shares vested and 2,194 shares were withheld for taxes, resulting in a net issuance of 2,756 shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."}],"balance_after":15192,"source":{"system":"sec-edgar","filing":"0001903669-25-000006","document":"form4-12132025_121210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000006/form4-12132025_121210.xml","form_type":"4"}},{"id":971432,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-12-13T00:03:14.000Z","date":"2025-12-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":428,"price":85.67,"value":36666.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 14, 2024, the Reporting Person was granted a total of 4,784 RSU's.  Subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date, 25% of the total number of RSUs vested on December 10, 2025, the first anniversary of the achievement of a specified clinical development objective.  25% of the total number of RSUs will vest on each of the second, third and fourth anniversaries of such achievement.  On December 10, 2025, 1,196 shares vested and 428 shares were withheld for taxes, resulting in a net issuance of 768 shares."}],"balance_after":10242,"source":{"system":"sec-edgar","filing":"0001903669-25-000006","document":"form4-12132025_121210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000006/form4-12132025_121210.xml","form_type":"4"}},{"id":971431,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-12-13T00:03:14.000Z","date":"2025-12-10","kind":"exercise","planned":false,"acquired":true,"shares":1196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 14, 2024, the Reporting Person was granted a total of 4,784 RSU's.  Subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date, 25% of the total number of RSUs vested on December 10, 2025, the first anniversary of the achievement of a specified clinical development objective.  25% of the total number of RSUs will vest on each of the second, third and fourth anniversaries of such achievement.  On December 10, 2025, 1,196 shares vested and 428 shares were withheld for taxes, resulting in a net issuance of 768 shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."}],"balance_after":10670,"source":{"system":"sec-edgar","filing":"0001903669-25-000006","document":"form4-12132025_121210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000006/form4-12132025_121210.xml","form_type":"4"}},{"id":1014840,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-10-22T20:15:05.000Z","date":"2025-10-20","kind":"exercise","planned":false,"acquired":false,"shares":4784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\")  represents a contingent right to receive one share of SPRB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 14, 2024, the Reporting Person was granted 4,784 performance-based RSUs. On October 20, 2025, the Issuer's Board of Directors certified that certain specified performance goals were met and all of the RSUs vested. 1,539 shares were withheld for taxes, resulting in a net issuance of 3,245 shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On March 14, 2024, the Reporting Person was granted 4,784 performance-based RSUs. On October 20, 2025, the Issuer's Board of Directors certified that certain specified performance goals were met and all of the RSUs vested. 1,539 shares were withheld for taxes, resulting in a net issuance of 3,245 shares."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4784},"source":{"system":"sec-edgar","filing":"0001903669-25-000003","document":"form4-10222025_041001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000003/form4-10222025_041001.xml","form_type":"4"}},{"id":1014839,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-10-22T20:15:05.000Z","date":"2025-10-20","kind":"grant","planned":false,"acquired":true,"shares":4784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\")  represents a contingent right to receive one share of SPRB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 14, 2024, the Reporting Person was granted 4,784 performance-based RSUs. On October 20, 2025, the Issuer's Board of Directors certified that certain specified performance goals were met and all of the RSUs vested. 1,539 shares were withheld for taxes, resulting in a net issuance of 3,245 shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On March 14, 2024, the Reporting Person was granted 4,784 performance-based RSUs. On October 20, 2025, the Issuer's Board of Directors certified that certain specified performance goals were met and all of the RSUs vested. 1,539 shares were withheld for taxes, resulting in a net issuance of 3,245 shares."}],"balance_after":4784,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4784},"source":{"system":"sec-edgar","filing":"0001903669-25-000003","document":"form4-10222025_041001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000003/form4-10222025_041001.xml","form_type":"4"}},{"id":1014838,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-10-22T20:15:05.000Z","date":"2025-10-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":1539,"price":148.16,"value":228018.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 14, 2024, the Reporting Person was granted 4,784 performance-based RSUs. On October 20, 2025, the Issuer's Board of Directors certified that certain specified performance goals were met and all of the RSUs vested. 1,539 shares were withheld for taxes, resulting in a net issuance of 3,245 shares."}],"balance_after":9474,"source":{"system":"sec-edgar","filing":"0001903669-25-000003","document":"form4-10222025_041001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000003/form4-10222025_041001.xml","form_type":"4"}},{"id":1014837,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-10-22T20:15:05.000Z","date":"2025-10-20","kind":"exercise","planned":false,"acquired":true,"shares":4784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 14, 2024, the Reporting Person was granted 4,784 performance-based RSUs. On October 20, 2025, the Issuer's Board of Directors certified that certain specified performance goals were met and all of the RSUs vested. 1,539 shares were withheld for taxes, resulting in a net issuance of 3,245 shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit (\"RSU\")  represents a contingent right to receive one share of SPRB common stock."}],"balance_after":11013,"source":{"system":"sec-edgar","filing":"0001903669-25-000003","document":"form4-10222025_041001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000190366925000003/form4-10222025_041001.xml","form_type":"4"}},{"id":1324354,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-12-21T01:28:11.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":false,"shares":111000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On December 5, 2022, the Reporting Person was granted 444,000 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs vested on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 111,000 RSUs vested, with 39,605 shares withheld for taxes, resulting in a net issuance of 71,395 shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On December 5, 2022, the Reporting Person was granted 444,000 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs vested on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 111,000 RSUs vested, with 39,605 shares withheld for taxes, resulting in a net issuance of 71,395 shares."}],"balance_after":222000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":111000},"source":{"system":"sec-edgar","filing":"0001415889-24-029999","document":"form4-12212024_011208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000141588924029999/form4-12212024_011208.xml","form_type":"4"}},{"id":1324353,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-12-21T01:28:11.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":false,"shares":89700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 14, 2023, the Reporting Person was granted a total of 717,600 RSUs. 50% or 358,800 of the total RSUs are performance-based and since certain specified performance goals were met, they all vested on December 10, 2024.  An addition of 50% or 358,800 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 89,700 shares vested and 32,005 shares were withheld for taxes, resulting in a net issuance of 57,695 shares. An additional"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On December 14, 2023, the Reporting Person was granted a total of 717,600 RSUs. 50% or 358,800 of the total RSUs are performance-based and since certain specified performance goals were met, they all vested on December 10, 2024.  An addition of 50% or 358,800 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 89,700 shares vested and 32,005 shares were withheld for taxes, resulting in a net issuance of 57,695 shares. An additional"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents the aggregate balance of time-based RSUs."}],"balance_after":269100,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":89700},"source":{"system":"sec-edgar","filing":"0001415889-24-029999","document":"form4-12212024_011208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000141588924029999/form4-12212024_011208.xml","form_type":"4"}},{"id":1324352,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-12-21T01:28:11.000Z","date":"2024-12-10","kind":"exercise","planned":false,"acquired":false,"shares":358800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 14, 2023, the Reporting Person was granted a total of 717,600 RSUs. 50% or 358,800 of the total RSUs are performance-based and since certain specified performance goals were met, they all vested on December 10, 2024.  An addition of 50% or 358,800 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 89,700 shares vested and 32,005 shares were withheld for taxes, resulting in a net issuance of 57,695 shares. An additional"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On December 14, 2023, the Reporting Person was granted a total of 717,600 RSUs. 50% or 358,800 of the total RSUs are performance-based and since certain specified performance goals were met, they all vested on December 10, 2024.  An addition of 50% or 358,800 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 89,700 shares vested and 32,005 shares were withheld for taxes, resulting in a net issuance of 57,695 shares. An additional"}],"balance_after":358800,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":358800},"source":{"system":"sec-edgar","filing":"0001415889-24-029999","document":"form4-12212024_011208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000141588924029999/form4-12212024_011208.xml","form_type":"4"}},{"id":1324351,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-12-21T01:28:11.000Z","date":"2024-12-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":39605,"price":0.3887,"value":15394.4635,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On December 5, 2022, the Reporting Person was granted 444,000 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs vested on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 111,000 RSUs vested, with 39,605 shares withheld for taxes, resulting in a net issuance of 71,395 shares."}],"balance_after":467191,"source":{"system":"sec-edgar","filing":"0001415889-24-029999","document":"form4-12212024_011208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000141588924029999/form4-12212024_011208.xml","form_type":"4"}},{"id":1324350,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-12-21T01:28:11.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":true,"shares":111000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On December 5, 2022, the Reporting Person was granted 444,000 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs vested on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 111,000 RSUs vested, with 39,605 shares withheld for taxes, resulting in a net issuance of 71,395 shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."}],"balance_after":506796,"source":{"system":"sec-edgar","filing":"0001415889-24-029999","document":"form4-12212024_011208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000141588924029999/form4-12212024_011208.xml","form_type":"4"}},{"id":1324349,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-12-21T01:28:11.000Z","date":"2024-12-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":32005,"price":0.3887,"value":12440.3435,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 14, 2023, the Reporting Person was granted a total of 717,600 RSUs. 50% or 358,800 of the total RSUs are performance-based and since certain specified performance goals were met, they all vested on December 10, 2024.  An addition of 50% or 358,800 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 89,700 shares vested and 32,005 shares were withheld for taxes, resulting in a net issuance of 57,695 shares. An additional"}],"balance_after":395796,"source":{"system":"sec-edgar","filing":"0001415889-24-029999","document":"form4-12212024_011208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000141588924029999/form4-12212024_011208.xml","form_type":"4"}},{"id":1324348,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-12-21T01:28:11.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":true,"shares":89700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 14, 2023, the Reporting Person was granted a total of 717,600 RSUs. 50% or 358,800 of the total RSUs are performance-based and since certain specified performance goals were met, they all vested on December 10, 2024.  An addition of 50% or 358,800 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 89,700 shares vested and 32,005 shares were withheld for taxes, resulting in a net issuance of 57,695 shares. An additional"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."}],"balance_after":427801,"source":{"system":"sec-edgar","filing":"0001415889-24-029999","document":"form4-12212024_011208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000141588924029999/form4-12212024_011208.xml","form_type":"4"}},{"id":1324347,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-12-21T01:28:11.000Z","date":"2024-12-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":128020,"price":0.537,"value":68746.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 14, 2023, the Reporting Person was granted a total of 717,600 RSUs. 50% or 358,800 of the total RSUs are performance-based and since certain specified performance goals were met, they all vested on December 10, 2024.  An addition of 50% or 358,800 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 89,700 shares vested and 32,005 shares were withheld for taxes, resulting in a net issuance of 57,695 shares. An additional"}],"balance_after":338101,"source":{"system":"sec-edgar","filing":"0001415889-24-029999","document":"form4-12212024_011208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000141588924029999/form4-12212024_011208.xml","form_type":"4"}},{"id":1324346,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-12-21T01:28:11.000Z","date":"2024-12-10","kind":"exercise","planned":false,"acquired":true,"shares":358800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 14, 2023, the Reporting Person was granted a total of 717,600 RSUs. 50% or 358,800 of the total RSUs are performance-based and since certain specified performance goals were met, they all vested on December 10, 2024.  An addition of 50% or 358,800 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 89,700 shares vested and 32,005 shares were withheld for taxes, resulting in a net issuance of 57,695 shares. An additional"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."}],"balance_after":466121,"source":{"system":"sec-edgar","filing":"0001415889-24-029999","document":"form4-12212024_011208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000141588924029999/form4-12212024_011208.xml","form_type":"4"}},{"id":1572725,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-03-18T20:27:29.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":358800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of SPRB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person's Continuous Service as of each such vesting date, 25% of the total number of RSUs vests upon each of the first, second, third and fourth anniversaries of the achievement of a specified clinical development objective."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person's Continuous Service as of each such vesting date, 25% of the total number of RSUs vests upon each of the first, second, third and fourth anniversaries of the achievement of a specified clinical development objective."}],"balance_after":358800,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":358800},"source":{"system":"sec-edgar","filing":"0001415889-24-008264","document":"form4-03182024_080323.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000141588924008264/form4-03182024_080323.xml","form_type":"4"}},{"id":1707579,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-12-19T01:15:50.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":false,"shares":111000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 5, 2022, the Reporting Person was granted 444,000 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs to vest on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2023, 111,000 RSUs vested, with 38,384 shares being withheld for taxes, resulting in a net issuance of 72,616 shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On December 5, 2022, the Reporting Person was granted 444,000 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs to vest on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2023, 111,000 RSUs vested, with 38,384 shares being withheld for taxes, resulting in a net issuance of 72,616 shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Represents the aggregate balance of 333,000 time-based RSUs."}],"balance_after":333000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":111000},"source":{"system":"sec-edgar","filing":"0001209191-23-059053","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000120919123059053/doc4.xml","form_type":"4"}},{"id":1707578,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-12-19T01:15:50.000Z","date":"2023-12-14","kind":"grant","planned":false,"acquired":true,"shares":717600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"358,800 of the RSUs shall vest as to 25% on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"358,800 of the RSUs shall vest upon the achievement of specified performance goals, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"358,800 of the RSUs shall vest as to 25% on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"358,800 of the RSUs shall vest upon the achievement of specified performance goals, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."}],"balance_after":717600,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":717600},"source":{"system":"sec-edgar","filing":"0001209191-23-059053","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000120919123059053/doc4.xml","form_type":"4"}},{"id":1707577,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-12-19T01:15:50.000Z","date":"2023-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":38384,"price":1.66,"value":63717.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 5, 2022, the Reporting Person was granted 444,000 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs to vest on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2023, 111,000 RSUs vested, with 38,384 shares being withheld for taxes, resulting in a net issuance of 72,616 shares."}],"balance_after":107321,"source":{"system":"sec-edgar","filing":"0001209191-23-059053","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000120919123059053/doc4.xml","form_type":"4"}},{"id":1707576,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-12-19T01:15:50.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":true,"shares":111000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 5, 2022, the Reporting Person was granted 444,000 time-based restricted stock units (\"RSUs\"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs to vest on December 15, 2023 (the \"Annual Vesting Date\") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2023, 111,000 RSUs vested, with 38,384 shares being withheld for taxes, resulting in a net issuance of 72,616 shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of SPRB common stock."}],"balance_after":145705,"source":{"system":"sec-edgar","filing":"0001209191-23-059053","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000120919123059053/doc4.xml","form_type":"4"}},{"id":1728796,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-11-29T00:00:09.000Z","date":"2023-11-26","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On January 3, 2022, the Reporting Person was granted a stock option to purchase 250,000 shares of the Issuer's common stock. The shares subject to the stock option shall vest upon the achievement of specified performance goals, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). Certain specified performance goals were met, resulting in the vesting of 125,000 shares subject to the stock option."}],"balance_after":125000,"derivative":{"exercise_price":4.59,"exercise_date":"2023-11-26","expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-23-056836","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000120919123056836/doc4.xml","form_type":"4"}},{"id":1836873,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-05T22:01:43.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0.9775,"value":19550.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":34705,"source":{"system":"sec-edgar","filing":"0001209191-23-041260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000120919123041260/doc4.xml","form_type":"4"}},{"id":2063191,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-06T01:12:36.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":14705,"price":0.9328,"value":13716.824,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The Reporting Person acquired the maximum shares allowable pursuant to Section 423 of the Internal Revenue Code."}],"balance_after":14705,"source":{"system":"sec-edgar","filing":"0001209191-23-002152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000120919123002152/doc4.xml","form_type":"4"}},{"id":2093519,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-12-08T01:02:29.000Z","date":"2022-12-05","kind":"grant","acquired":true,"shares":444000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest over four years. 25% of the RSUs will vest on December 15, 2023 (the \"Annual Vesting Date\"), and 25% of the total number of RSUs will vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest over four years. 25% of the RSUs will vest on December 15, 2023 (the \"Annual Vesting Date\"), and 25% of the total number of RSUs will vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."}],"balance_after":444000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":444000},"source":{"system":"sec-edgar","filing":"0001209191-22-060274","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000120919122060274/doc4.xml","form_type":"4"}},{"id":2439026,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-01-11T02:07:34.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest upon the achievement of specified performance goals, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."}],"balance_after":250000,"derivative":{"exercise_price":4.59,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-22-002772","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000120919122002772/doc4.xml","form_type":"4"}},{"id":2439025,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":31240,"kind":"person","name":"Szwarcberg Javier B.","position":1,"cik":"0001903669","reported_name":"Szwarcberg Javier B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-01-11T02:07:34.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the stock option vest over a four-year period commencing January 3, 2022, with 1/4th of the shares vesting on January 3, 2023 and 1/36th of the remaining shares vesting on a monthly basis, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."}],"balance_after":750000,"derivative":{"exercise_price":4.59,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001209191-22-002772","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1903669/000120919122002772/doc4.xml","form_type":"4"}}]}